中文
CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production
September 14, 2021
READ ARTICLECategory: News & Press
AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics
July 20, 2021
READ ARTICLE AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
January 7, 2021
READ ARTICLE Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop and Market Corticotropin Injection
August 10, 2020
READ ARTICLE Adalvo and AmbioPharm partner on development & licensing for key peptide products
July 29, 2020
READ ARTICLE Covid-19 update at AmbioPharm
March 25, 2020
READ ARTICLE